Conrad Smith

524 total citations
15 papers, 343 citations indexed

About

Conrad Smith is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Conrad Smith has authored 15 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Conrad Smith's work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Coronary Interventions and Diagnostics (9 papers) and Acute Myocardial Infarction Research (5 papers). Conrad Smith is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Coronary Interventions and Diagnostics (9 papers) and Acute Myocardial Infarction Research (5 papers). Conrad Smith collaborates with scholars based in United States, Canada and Palestinian Territory. Conrad Smith's co-authors include Suresh Mulukutla, Oscar C. Marroquin, Joon S. Lee, Sheryl F. Kelsey, David O. Williams, Kevin E. Kip, Helen Vlachos, J. Dawn Abbott, Elizabeth M. Holper and William Anderson and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The American Journal of Cardiology.

In The Last Decade

Conrad Smith

12 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Conrad Smith United States 8 299 270 99 67 9 15 343
Mauro Pennacchi Italy 9 228 0.8× 199 0.7× 114 1.2× 64 1.0× 6 0.7× 26 321
Knud Noerregaard Hansen Denmark 10 335 1.1× 315 1.2× 163 1.6× 72 1.1× 11 1.2× 12 405
Andrea Micheli Italy 8 214 0.7× 259 1.0× 177 1.8× 45 0.7× 4 0.4× 12 333
Ben Kirkland United States 7 325 1.1× 286 1.1× 224 2.3× 63 0.9× 3 0.3× 8 387
Hans-Henrik Tilsted Denmark 9 198 0.7× 232 0.9× 141 1.4× 22 0.3× 6 0.7× 15 283
Simona Giubilato Italy 8 209 0.7× 224 0.8× 169 1.7× 28 0.4× 9 1.0× 24 314
Geoffrey D. Cope Australia 9 151 0.5× 343 1.3× 98 1.0× 55 0.8× 5 0.6× 19 419
Jorge Martı́nez United States 4 320 1.1× 291 1.1× 160 1.6× 48 0.7× 9 1.0× 8 376
Gaetano Contegiacomo Italy 7 224 0.7× 204 0.8× 157 1.6× 61 0.9× 6 0.7× 27 290
Elie Gharib United States 7 292 1.0× 249 0.9× 39 0.4× 82 1.2× 4 0.4× 12 325

Countries citing papers authored by Conrad Smith

Since Specialization
Citations

This map shows the geographic impact of Conrad Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad Smith more than expected).

Fields of papers citing papers by Conrad Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad Smith. The network helps show where Conrad Smith may publish in the future.

Co-authorship network of co-authors of Conrad Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Conrad Smith. A scholar is included among the top collaborators of Conrad Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conrad Smith. Conrad Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Efimenko, Evgeni, et al.. (2025). Preclinical Efficacy of a Hemostatic Agent in Overcoming Dual Antiplatelet Therapy. JACC Basic to Translational Science. 10(9). 101356–101356.
2.
Allana, Salman, Mohamad Alkhouli, Megan Coylewright, et al.. (2021). Identifying opportunities to advance health equity in interventional cardiology: Structural heart disease. Catheterization and Cardiovascular Interventions. 99(4). 1165–1171. 1 indexed citations
3.
Smith, Conrad, et al.. (2021). Novel method for transaxillary Impella 5.0 implantation in patients with tortuous arterial anatomy. SHILAP Revista de lepidopterología. 9(7). e04186–e04186. 1 indexed citations
4.
Kapoor, Saloni, Jianhui Zhu, Arman Kilic, et al.. (2021). Outcomes in Multivessel Coronary Disease Stratified by The Society of Thoracic Surgeons Risk. The Annals of Thoracic Surgery. 114(2). 442–449.
6.
Sharbaugh, Michael, Oscar C. Marroquin, Catalin Toma, et al.. (2019). Impact of Chronic Kidney Disease and Anemia on Outcomes After Percutaneous Coronary Revascularization. The American Journal of Cardiology. 124(6). 851–856. 13 indexed citations
7.
Mulukutla, Suresh, Thomas G. Gleason, Michael Sharbaugh, et al.. (2019). Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease. The Annals of Thoracic Surgery. 108(2). 474–480. 23 indexed citations
8.
Kilic, Arman, Ibrahim Sultan, Thomas G. Gleason, et al.. (2019). Surgical versus percutaneous multivessel coronary revascularization in patients with chronic kidney disease. European Journal of Cardio-Thoracic Surgery. 57(5). 994–1000. 9 indexed citations
9.
Mulukutla, Suresh, Oscar C. Marroquin, Helen Vlachos, et al.. (2012). Benefit of Long-Term Dual Anti-Platelet Therapy in Patients Treated With Drug-Eluting Stents: From the NHLBI Dynamic Registry. The American Journal of Cardiology. 111(4). 486–492. 30 indexed citations
10.
Wolf, William M., Helen Vlachos, Oscar C. Marroquin, et al.. (2010). Paclitaxel-Eluting Versus Sirolimus-Eluting Stents in Diabetes Mellitus. Circulation Cardiovascular Interventions. 3(1). 42–49. 11 indexed citations
11.
Marroquin, Oscar C., Faith Selzer, Suresh Mulukutla, et al.. (2008). A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications. New England Journal of Medicine. 358(4). 342–352. 179 indexed citations
12.
Mulukutla, Suresh, Helen Vlachos, Oscar C. Marroquin, et al.. (2008). Impact of Drug-Eluting Stents Among Insulin-Treated Diabetic Patients. JACC: Cardiovascular Interventions. 1(2). 139–147. 35 indexed citations
13.
Suzuki, Nobuaki, Dominick J. Angiolillo, Mark Tannenbaum, et al.. (2008). Strategies for drug‐eluting stent treatment of bifurcation coronary artery disease in the United States: Insights from the e‐Cypher S.T.L.L.R.Trial. Catheterization and Cardiovascular Interventions. 73(7). 890–897. 5 indexed citations
14.
Mulukutla, Suresh, Oscar C. Marroquin, Conrad Smith, et al.. (2004). Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury. The American Journal of Cardiology. 94(11). 1363–1366. 33 indexed citations
15.
Smith, Conrad, et al.. (1983). The Health Care Meeting: Eight Years of Collaborative Work in General Practice. Group Analysis. 16(1). 52–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026